Treatment of 1st Line RCC selection of I-O and TKIs

Treatment of 1st Line RCC selection of I-O and TKIs

obr

11 months
75 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael B. Atkins MD at Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology discusses how to select between different combinations of immuno-oncology and TKIs that are available and for the treatment of 1st line renal cell carcinoma (RCC).
Up Next Autoplay